XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Current Assets    
Cash and cash equivalents $ 6,659 $ 7,965
Short-term investments 446 899
Accounts receivable (net of allowance for doubtful accounts of $122 in 2019 and $119 in 2018) 7,964 7,071
Inventories (excludes inventories of $1,464 in 2019 and $1,417 in 2018 classified in Other assets - see Note 6) 5,847 5,440
Other current assets 3,382 4,500
Total current assets 24,298 25,875
Investments 3,779 6,233
Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,049 in 2019 and $16,324 in 2018 13,862 13,291
Goodwill 19,490 18,253
Other Intangibles, Net 13,381 11,431
Other Assets 9,155 7,554
Total Assets 83,965 82,637
Current Liabilities    
Loans payable and current portion of long-term debt 3,816 5,308
Trade accounts payable 3,142 3,318
Accrued and other current liabilities 11,054 10,151
Income taxes payable 634 1,971
Dividends payable 1,439 1,458
Total current liabilities 20,085 22,206
Long-Term Debt 22,771 19,806
Deferred Income Taxes 2,089 1,702
Other Noncurrent Liabilities 11,283 12,041
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2019 and 2018 1,788 1,788
Other paid-in capital 39,484 38,808
Retained earnings 45,295 42,579
Accumulated other comprehensive loss (5,362) (5,545)
Stockholders' equity before deduction for treasury stock 81,205 77,630
Less treasury stock, at cost: 1,010,308,500 shares in 2019 and 984,543,979 shares in 2018 53,570 50,929
Total Merck & Co., Inc. stockholders’ equity 27,635 26,701
Noncontrolling Interests 102 181
Total equity 27,737 26,882
Liabilities and Equity $ 83,965 $ 82,637